DCGI approves clinical trials of Favipiravir used in influenza in Japan, China for COVID-19: CISR Director General

New Delhi, May 08 (ANI): The Certified Insurance Service Representative (CISR) Director General Dr. Shekhar C. Mande while talking about drugs that can be useful against COVID-19 informed that the Drug Controller General of India has given approval for clinical trials of Favipiravir which is used in influenza in Japan, China etc. he said that it can be “potentially useful against COVID-19 and a phytopharmaceutical which is an extract of a plant”.